More News

16 Oct 2017 Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections
16 Oct 2017 ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections
13 Oct 2017 Elsalys Biotech acquires from Jazz Pharmaceuticals the worldwide rights of Leukotac®
12 Oct 2017 Merz and Teijin Announce Partnership to Bring Xeomin® (incobotulinumtoxinA) to Japan
12 Oct 2017 Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
12 Oct 2017 Karyopharm and Ono Pharmaceutical Co. Ltd. Sign Exclusive License Agreement to Develop and Commercialize Selinexor and KPT-8602 in Japan and Other Countries in Asia
11 Oct 2017 GamaMabs and MedImmune Enter Licensing Agreement to Develop Antibody Drug Conjugate Targeting Cancer
11 Oct 2017 Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct “JOINUS,” a New Drug Discovery Program Using Drug-Repositioning Compound Library
10 Oct 2017 KalVista Pharmaceuticals Announces Collaboration with Merck
10 Oct 2017 AbbVie and Turnstone Biologics Announce Global Collaboration on Viral Immunotherapies in Oncology
10 Oct 2017 Nicox and pSivida Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in Patients with Glaucoma
07 Oct 2017 PanOptica Secures $11 Million to Advance Clinical Development of PAN-90806 – a Novel, Topical Anti-VEGF Eye Drop
06 Oct 2017 Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing
05 Oct 2017 VITRUVIAN BioMedical Licenses New Alzheimer’s Vaccine Targeting ABeta + TAU
05 Oct 2017 Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics
05 Oct 2017 AMR Centre deal with Medivir targets superbug time-bomb
05 Oct 2017 Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments
05 Oct 2017 Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
04 Oct 2017 Palleon Pharmaceuticals Raises $47.6 Million to Develop Glycoimmune Checkpoint Inhibitors, a New Class of Medicines Designed to Overcome Resistance to First-Generation Immuno-Oncology Drugs
04 Oct 2017 Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors
04 Oct 2017 Nimbus Therapeutics and Celgene Enter Long-Term Strategic Immunology Alliance to Develop Programs for Patients with Autoimmune Disorders
04 Oct 2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
04 Oct 2017 Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
03 Oct 2017 Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors
03 Oct 2017 Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted Radioligand Therapy for Development in Prostate Cancer

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing